Intravenous immunoglobulin to treat severe atopic dermatitis in children: A case series

Pediatric Dermatology

Volumn 29, Issue 2, 2012, Pages 177-181

  Turner, Paul J ^a,b   Kakakios, Alyson ^a,b   Wong, Li Chuen ^a   Wong, Melanie ^a   Campbell, Dianne E ^a,b  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G;

ABSENTEEISM; ACADEMIC ACHIEVEMENT; ADOLESCENT; ARTICLE; ATOPIC DERMATITIS; CHILD; CLINICAL ARTICLE; DISEASE EXACERBATION; DRUG EFFICACY; DRUG MEGADOSE; EOSINOPHIL COUNT; FEMALE; HOSPITALIZATION; HUMAN; IMMUNE DEFICIENCY; IMMUNOGLOBULIN BLOOD LEVEL; MALE; MEDICAL RECORD REVIEW; PRESCHOOL CHILD; PRIORITY JOURNAL; QUALITY OF LIFE; RELAPSE; REMISSION; RETROSPECTIVE STUDY; SCHOOL CHILD; SLEEP QUALITY; THERAPY EFFECT; TREATMENT DURATION; TREATMENT RESPONSE;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; FEMALE; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; MALE; QUALITY OF LIFE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84859108238     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2011.01654.x     Document Type: Article

References (14)

1. Williams H, Robertson C, Stewart AJ, et al., Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol 1999; 103: 125-138.
2. Prins C, Gelfand EW, French LE,. Intravenous immunoglobulin: properties, mode of action and practical use in dermatology. Acta Dermatol Venereol 2007; 87: 206-218.
3. Jolles S,. A review of high-dose intravenous immunoglobulin treatment for atopic dermatitis. Clin Exp Dermatol 2002; 27: 3-7.
4. Kimata H,. High dose gammaglobulin treatment for atopic dermatitis. Arch Dis Child 1994; 70: 335-336.
5. Paul C, Lahfa M, Bachelez H, et al., A randomized controlled evaluator-blinded trial of intravenous immunoglobulin in adults with severe atopic dermatitis. Br J Dermatol 2002; 147: 518-522.
6. Darsow U, Wollenberg A, Simon D, et al., ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis. J Eur Acad Dermatol Venerol 2010; 24: 317-328.
7. Schimke LF, Sawalle-Belohradsky J, Roesler J, et al., Diagnostic approach to the hyper-IgE syndromes: Immunologic and clinical key findings to differentiate hyper-IgE syndromes from atopic dermatitis. J Allergy Clin Immunol 2010; 126: 611-617.
8. Lamb S, Rademaker M,. Intravenous immunoglobulin therapy for the treatment of severe atopic dermatitis. Exp Opin Pharmacother 2001; 2: 67-74.
9. Elias PM, Schmuth M,. Abnormal skin barrier in the etiopathogenesis of atopic dermatitis. Curr Opin Allergy Clin Immunol 2009; 9: 437-446.
10. Weiss S, Schuval S, Bonagura V,. Eczema and thrombocytopenia in an 8-month-old infant boy. Ann Allergy Asthma Immunol 1997; 78: 179-182.
11. Wakim M, Alazard M, Yajima A, et al., High dose intravenous immunoglobulin in atopic dermatitis and hyper-IgE syndrome. Ann Allergy Asthma Immunol 1998; 81: 153-158.
12. Huang J, Lee W, Chen L, et al., Changes of serum levels of interleukin-2, intercellular adhesion molecule-1, endothelial leukocyte adhesion molecule-1 and Th1 and Th2 cell in severe atopic dermatitis after intravenous immunoglobulin therapy. Ann Allergy Asthma Immunol 2000; 84: 345-352.
13. Noh G, Lee KY,. Intravenous immune globulin (IVIG) therapy in steroid-resistant atopic dermatitis. J Korean Med Sci 1999; 14: 63-68.
14. Bemanian MH, Movahedi M, Farhoudi A, et al., High doses intravenous immunoglobulin versus oral cyclosporine in the treatment of severe atopic dermatitis. Iran J Allergy Asthma Immunol 2005; 4: 139-143.